Developmental Research Program

发展研究计划

• 批准号: 10554479
• 负责人: Eric R. Fearon
• 金额: $ 15.08万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-14 至 2028-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10554479
• 关键词: Advertisements; Award; Basic Science; Biometry; Budgets; Cancer Center; Clinical; Collaborations; Communities; Data Reporting; Development; Early treatment; Elements; Ensure; Evaluation; Exclusion; Faculty; Feedback; Fostering; Funding; Future; Goals; Grant; Human; Institution; Laboratories; Locally Advanced Malignant Neoplasm; Mentors; Mentorship; Michigan; Molecular Target; Monitor; Outcome; Population Research; Process; Program Research Project Grants; Protocols documentation; Radiation therapy; Radiosensitization; Research; Research Personnel; Research Project Grants; Research Proposals; Resources; Schedule; Seasons; Treatment-Related Cancer; United States National Institutes of Health; Universities; Writing; anticancer research; career; data submission; expectation; high risk; innovation; member; novel; operation; peer; pre-clinical; programs; translational impact; translational potential; web site

PROJECT SUMMARY-ABSTRACT (DEVELOPMENTAL RESEARCH PROGRAM) Support for developmental research projects are a key SPORE element and are vital for fostering pioneering initiatives. As such, we will support 3 developmental research projects with budgets of approximately $50,000 each per year. The principal goal of the Developmental Research Program (DRP) is to support highly innovative radiation therapy related cancer research with high potential for translational impact, allowing investigators the ability to obtain key preliminary data for submission of an R01 application or an equivalent proposal (e.g. project in future SPORE application). A maximum of two years of support will be possible; however, the expectation is that funds will support most projects for one year, with 10-15 new projects supported during the five-year period of the grant. Projects will be solicited from University of Michigan Rogel Cancer Center investigators and other University of Michigan faculty by campus-wide announcements and a standing advertisement for the Program at the Cancer Center and institutional websites listing other developmental research opportunities. Applications will utilize an NIH format, with a 5-page limit on the body of the application (e.g. excluding references, detailed protocol information, appendix materials). Drs. Eric Fearon and Theodore Lawrence will serve as Co-Directors of the DRP. The Cancer Research Committee of the University of Michigan Rogel Cancer Center will undertake initial review, evaluating each proposal’s scientific merit, innovation, relevance to the theme of radiosensitization of locally advanced cancers and potential for translational impact. Given the Cancer Research Committee’s rapid and successful annual review of more than 100 pilot research proposals yearly in laboratory, clinical, and population-based research, the Committee is well-suited for the initial review process. After initial review, the SPORE’s Operations Committee will utilize assigned merit scores as a principal, but not sole, criterion in the selection of proposals for support. Developmental research project investigators will take part in all SPORE activities. Drs. Fearon or Lawrence will join mentoring committees set up for each project PI to offer in-depth review and mentorship.

项目摘要-摘要（发展性研究项目）